Results 81 to 90 of about 63,717 (177)

Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study. [PDF]

Blood Adv
Gotlib J, Reiter A, Radia DH, Álvarez-Twose I, Deininger MW, George TI, Panse J, Mital A, Pettit KM, Vannucchi AM, Platzbecker U, Hermine O, Elshoury A, Livideanu CB, Mesa R, Ustun C, Triggiani M, Dybedal I, Jurcic JG, Zanotti R, Oh ST, Yacoub A, Hexner EO, Bose P, Lee SG, Sperr WR, Griffiths EA, Butler M, Lübke J, Bidollari I, Lin HM, Rylova S, Dimitrijević S, Muñoz-González JI, DeAngelo DJ.   +34 more
europepmc   +1 more source

Nemolizumab as an Alternative Therapeutic Option for Indolent Systemic Mastocytosis. [PDF]

Cureus
Minbaeva S, Tyring SK.
europepmc   +1 more source

Refractory cutaneous symptoms in systemic mastocytosis. [PDF]

JAAD Case Rep
Gleason L, Bhatti SA, Wallace M, Lee JB, Alpdogan O, Nikbakht N.   +5 more
europepmc   +1 more source

Symptom patterns before and after indolent systemic mastocytosis: A matched cohort analysis. [PDF]

J Allergy Clin Immunol Glob
Tse KY, Zhou M, Zeiger RS, Avila C, Saparudin M, Atif H, Puttock EJ, Lampson B, Xie F, Miller K, Powell D, Sullivan E, Yuen C, Chen W.   +13 more
europepmc   +1 more source

Assessing real-world natural history of indolent systemic mastocytosis: A retrospective matched cohort study. [PDF]

J Allergy Clin Immunol Glob
Pongdee T, Powell D, Weis T, Scherber R, Green T, Smither A, Krishnappa P, Carlson K, Singh P, Duff S, Sullivan E.   +10 more
europepmc   +1 more source

Clinical Spectrum of Drug Hypersensitivity Reactions in Systemic Mastocytosis: Drug-Induced Anaphylaxis as a Unique Clinical Presentation. [PDF]

Medicina (Kaunas)
Aslan E, Okan K, Kural RF, İnan S, Özeke Y, Ateş Ü, Yıldırım O, Galata Z, Kırdök K, Ay E, Dizdar Canbaz T, Toksoy Şentürk Mİ, Karaaslan Yetemen S, Gümüşburun R, Akten HS, Aytaç H, Özışık M, Çamyar A, Demiroğlu G, Bulut G, Demir M, Soyer N, Keklik Karadağ F, Demir D, Hekimgil M, Özsan N, Şarer Yürekli BP, Karaca E, Durmaz MB, Tunakan Dalgıç C, Kokuludağ A, Sin AZ, Mete Gökmen EN.   +32 more
europepmc   +1 more source

Avapritinib and corticosteroids in advanced systemic mastocytosis with tumoral CMML and associated thrombocytopenia. [PDF]

Oxf Med Case Reports
Abakarim O, Jeddi R, Rossignol J, Hermine O, Delabesse E, Condom P, Laurent C, Botin T.   +7 more
europepmc   +1 more source

Gallbladder Involvement in Aggressive Systemic Mastocytosis. [PDF]

Turk J Haematol
Koç A, Akyol H, Mastanzade M, Keşmer S, Erdem S.   +4 more
europepmc   +1 more source

Systemic Mastocytosis, KIT and the Effects of KIT Tyrosine Kinase Inhibitors on Mast Cell and Basophil Activation. [PDF]

Curr Allergy Asthma Rep
Valent P, Hartmann K, Stefanzl G, Filik Y, Bauer K, Degenfeld-Schonburg L, Gleixner KV, Siebenhaar F, Niedoszytko M, Sperr WR, Aghaallaei N, Hoermann G, Sabato V, Orfao A, Arock M, Akin C.   +15 more
europepmc   +1 more source

Using natural language processing to identify symptoms in systemic mastocytosis. [PDF]

JAMIA Open
Xie F, Tse KY, Avila CC, Zhou M, Saparudin M, Atif H, Zeiger RS, Miller K, Powell D, Sullivan E, Lampson B, Puttock EJ, Yuen C, Chen W.   +13 more
europepmc   +1 more source